Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 50 drugs
No. | DrugBank | 薬物名(臨床試験情報から抽出) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acetylcysteine | 3件: Acetylcysteine Acetylcysteine; Mucomyst; N-acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬1. Acetylcysteine
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬1. Acetylcysteine
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Alemtuzumab | 4件: Alemtuzumab Alemtuzumab; Campath; Lemtrada; MABCAMPATH | 1件: Alemtuzumab
Alemtuzumab
💬2. Alemtuzumab
| 1件: CD52 CD52 💬2. Alemtuzumab
| - | 22件: 13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬2. Alemtuzumab
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Aminophylline | 1件: Aminophylline Aminophylline | 1件: Aminophylline
Aminophylline
💬3. Aminophylline
| 18件: ADORA1 ADORA1,ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 18件: ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, ... 3. Aminophylline
| 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pa ... | 1件: 63 63 💬3. Aminophylline
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Amoxicillin | 4件: Amoxicilina Amoxicilina; AMOXICILLIN; Amoxycillin; Augmentin | 2件: Amoxicillin
Amoxicillin
,Amoxicillin 💬 4. Amoxicillin
| - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 💬4. Amoxicillin
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Atorvastatin | 3件: Atorvastatin Atorvastatin; Atorvastatin calcium; Lipitor | 1件: Atorvastatin
Atorvastatin
💬5. Atorvastatin
| 1件: HMGCR HMGCR 💬5. Atorvastatin
| 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 19件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬5. Atorvastatin
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Avatrombopag | 2件: Avatrombopag Avatrombopag; Doptelet | 1件: Avatrombopag
Avatrombopag
💬6. Avatrombopag
| 1件: MPL MPL 💬6. Avatrombopag
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Azathioprine | 3件: Azathioprine Azathioprine; AZATIOPRINA; Imuran | 1件: Azathioprine
Azathioprine
💬7. Azathioprine
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬7. Azathioprine
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Belimumab | 2件: Belimumab Belimumab; BENLYSTA | 1件: Belimumab
Belimumab
💬8. Belimumab
| 1件: TNFSF13B TNFSF13B 💬8. Belimumab
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B ... | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬8. Belimumab
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Bevifimod | 1件: STAPHYLOCOCCAL PROTEIN A STAPHYLOCOCCAL PROTEIN A | - | - | - | 1件: 63 63 💬9. Bevifimod
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Blisibimod | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬10. Blisibimod
| - | - | 5件: 43 43, 44, 49, 63, 66 💬
|